United States · FDA National Drug Code directory
olmesartan medoxomil and amlodipine besylate and hydrochlorothiazide
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 70436-017_d306cb9e-4244-49dd-9297-9cb6ca69cae9
- Product NDC
- 70436-017
- Form
- TABLET, FILM COATED
- Composition / generic term
- olmesartan medoxomil and amlodipine besylate and hydrochlorothiazide
- Labeler
- Slate Run Pharmaceuticals, LLC
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20250515
- Source listing expiry
- 20261231
Source-listed ingredients
- OLMESARTAN MEDOXOMIL — 40 mg/1
- AMLODIPINE BESYLATE — 10 mg/1
- HYDROCHLOROTHIAZIDE — 12.5 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 30 TABLET, FILM COATED in 1 BOTTLE (70436-017-04) · 70436-017-04
- 90 TABLET, FILM COATED in 1 BOTTLE (70436-017-06) · 70436-017-06
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →